Generation of an iPSC line (SCTCi014-A) and isogenic control line (SCTCi014-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene

Stem Cell Res. 2022 Jul:62:102797. doi: 10.1016/j.scr.2022.102797. Epub 2022 Apr 30.

Abstract

Age-related macular degeneration (AMD) is a common eye disease among the elderly in the Western world. AMD is a multifactorial disease, with a strong association with genetic variation in the complement system. One of the AMD-associated variants is the c.355G>A (p.Gly119Arg) variant in complement factor I (CFI), a central regulator of complement activation. Here, we report the generation of an iPSC line and its isogenic wildtype control derived from peripheral blood mononuclear cells of a male AMD-affected individual carrying the heterozygous variant c.355G>A (p.Gly119Arg). The line can be utilized to study the effects of this variant in disease-specific cell types.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Complement Factor I / genetics
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Macular Degeneration* / genetics
  • Macular Degeneration* / metabolism
  • Male
  • Polymorphism, Single Nucleotide

Substances

  • Complement Factor I